Pediatric Pharmacology and Therapeutics

As a director of pediatric cardiology and pediatric intensive care unit, Jeng-Sheng Chang is specialized in diagnosis, management and follow-up of the congenital and acquired heart diseases in children. His team is team also integrated other subspeciality teams, including cardiovascular surgeon, anesthesiology, Pharmacists, respiration therapist, nurse practitioners and nutrionist, etc., for combining care of patients with critical disease his patient-centered projects for the critical heart disease children have won the grands for quality improvement, Taiwan Institute of Health and Welfare, 2015-2016 two successive years. The open heart surgery for congenital heart disease, interventional cardiac catheterization, Extracorporeal Membranous oxygenator(ECMO) therapy, and Kawasaki disease, both in clinical management and researches, are among our best works. His researches in Kawasaki disease, collaborative with the bench team in Central Research Institute, have published important papers in the Journals of Nature Genetics and Circulation Research. A biomarker for early detection of Kawasaki disease has also been put on the markets of Asian countries.